{"filing":{"accession_number":"0001493152-26-024639","cik":"0001178697","ticker":"SONM","company_name":"DNA X, Inc.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226024639/form8-k.htm"},"events":[{"id":9890,"run_id":8669,"accession_number":"0001493152-26-024639","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Item 2.02 discloses that DNA X, Inc. issued a press release on May 20, 2026 announcing financial results for the fiscal quarter ended March 31, 2026, with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.","company_name":"DNA X, Inc.","ticker":"SONM","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":714,"accession_number":"0001493152-26-024639","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 2.02 discloses that DNA X, Inc. issued a press release on May 20, 2026 announcing financial results for the fiscal quarter ended March 31, 2026, with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:53:46.993186+00:00","company_name":"DNA X, Inc.","ticker":"SONM","filing_date":"2026-05-20"}]}